Compare Stocks

→ “The Biggest Bubble of All Time” – Here’s What to Do. (From Chaikin Analytics) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
COG Cabot Oil & Gas		$17.89	$14.28 ▼ $23.10	$8.89B	0.15	8.21 million shs	1.24 million shs
ONC Oncolytics Biotech	C$1.48 +0.7%	C$1.44	C$1.20 ▼ C$4.49	C$111.62M	1.49	76,956 shs	37,308 shs
RENX Relx	$21.19	$0.00	$20.06 ▼ $23.30	N/A	N/A	100,590 shs	547,934 shs

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
COG Cabot Oil & Gas	0.00%	0.00%	0.00%	0.00%	0.00%
ONC Oncolytics Biotech	+2.80%	+2.08%	+5.00%	-13.53%	-5.16%
RENX Relx	0.00%	0.00%	0.00%	0.00%	0.00%

“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)

See this before next week's Fed Meeting Thousands of investing ideas come across his desk every year… But Doc Eifrig just revealed THIS ONE "will go down as one of the smartest and most lucrative financial moves of the decade." (Last time we shared this, it led to a 995% gain.)

Get the free details now.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
COG Cabot Oil & Gas	0.7828 of 5 stars	0.0	0.0	1.7	0.0	0.6	0.0	3.8
ONC Oncolytics Biotech	0.5584 of 5 stars	3.5	0.0	0.0	0.0	0.9	0.0	0.0
RENX Relx	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
COG Cabot Oil & Gas	N/A	N/A	N/A	N/A
ONC Oncolytics Biotech	3.00	Buy	C$6.00	305.41% Upside
RENX Relx	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest RENX, COG, GDR, and ONC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
4/4/2024	ONC Oncolytics Biotech	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Outperform	C$3.00

(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
COG Cabot Oil & Gas	$1.47B	0.00	N/A	12.93	$5.56 per share	0.00
ONC Oncolytics Biotech	N/A	N/A	C$0.35 per share	4.22	C$0.37 per share	N/A
RENX Relx	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
COG Cabot Oil & Gas	$200.53M	$0.43	28.90	0.00	0.19	19.77%	16.52%	8.16%	N/A
ONC Oncolytics Biotech	-C$27.75M	-C$0.41	N/A	∞	N/A	N/A	-102.66%	-55.47%	5/3/2024 (Estimated)
RENX Relx	N/A	$1.22	17.37	∞	N/A	N/A	N/A	N/A	N/A

Latest RENX, COG, GDR, and ONC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/7/2024	Q4 2023	ONC Oncolytics Biotech	-C$0.15	-C$0.05	+C$0.10	-C$0.05	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
COG Cabot Oil & Gas	$0.44	N/A	N/A	102.33%	N/A
ONC Oncolytics Biotech	N/A	N/A	N/A	N/A	N/A
RENX Relx	$0.28	1.32%	N/A	22.95%	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
COG Cabot Oil & Gas	0.41	1.05	1.00
ONC Oncolytics Biotech	1.54	9.01	8.86
RENX Relx	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
COG Cabot Oil & Gas	N/A
ONC Oncolytics Biotech	6.98%
RENX Relx	1.37%

Insider Ownership

Company	Insider Ownership
COG Cabot Oil & Gas	2.10%
ONC Oncolytics Biotech	6.24%
RENX Relx	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
COG Cabot Oil & Gas	503	399.66 million	N/A	Optionable
ONC Oncolytics Biotech	29	75.42 million	N/A	Not Optionable
RENX Relx	N/A	N/A	N/A	Not Optionable

RENX, COG, GDR, and ONC Headlines

Source	Headline
	Rex International Holding Full Year 2023 Earnings: US$0.049 loss per share (vs US$0.001 loss in FY 2022) au.finance.yahoo.com - March 31 at 6:28 PM
	Tossing Pinecones Into Mouth Of Giant T. Rex A 60-Year Laramie Tradition cowboystatedaily.com - March 31 at 6:28 PM
	T-Rex the cat gets wheelchair after losing front legs walb.com - March 31 at 2:33 AM
	Mar. 30: The Souled Out Show Band is putting on a party at The Rex manchesterinklink.com - March 30 at 9:33 PM
	Rex Chapman talks about his infamous shoe deal with AND1: "The shoes were not good and I started having problems" msn.com - March 30 at 4:33 PM
	Jinggg returns: Paper Rex’s 2024 VCT roster situation, explained dotesports.com - March 29 at 7:01 PM
	Paper Rex VALORANT star Jinggg returns early from mandatory military service, will rejoin team dotesports.com - March 29 at 7:01 PM
	Rex Brown Clarifies That Current Pantera Lineup “Is No Tribute Band” metalsucks.net - March 29 at 7:01 PM
	VALORANT: Jinggg returns to Paper Rex's main roster for VCT Pacific Split 1, Monyet shifted to reserve player msn.com - March 29 at 2:00 PM
	Paper Rex’s Jinggg returns as Valorant star avoids military service dexerto.com - March 29 at 2:00 PM
	REX BROWN On PANTERA: "This Is No Tribute Band" metalinjection.net - March 29 at 2:00 PM
	Paper Rex announces major change to Jinggg’s status on the team, impacting their future oneesports.gg - March 29 at 8:59 AM
	BHS holds ribbon-cutting for new baseball field honoring Rex and Brody Reinhart msn.com - March 29 at 8:59 AM
	Paper Rex announce Jinggg return and contract extension, Monyet benched siege.gg - March 29 at 8:59 AM
	"At the casino, you can really blow money" - Rex Chapman reveals he lost $12 million on gambling msn.com - March 29 at 8:59 AM
	Big news: Rex Davenport of Kenosha calls it a career after 51 years working in newspapers kenoshanews.com - March 29 at 8:59 AM
	UnitedHealth names John Rex president as Dirk McMahon retires modernhealthcare.com - March 28 at 9:00 PM
	A Look At The Intrinsic Value Of Rex International Holding Limited (SGX:5WH) finance.yahoo.com - March 28 at 9:00 PM
	Mansfield woman runs around town in T-Rex costume to raise money for Boston Marathon turnto10.com - March 28 at 9:00 PM
	REX American Resources Corp (REX) Reports Robust Fiscal Year Earnings, Surpassing Analyst ... finance.yahoo.com - March 28 at 3:59 PM
	T-Rex the two-legged the cat gifted new wheels woodtv.com - March 28 at 3:59 PM
	REX TRUEFORM GROUP LIMITED – Changes to the board of directors moneyweb.co.za - March 28 at 8:07 AM
	REX: Fiscal Q4 Earnings Snapshot thehour.com - March 28 at 8:07 AM
	REX American Resources Corporation Q4 Profit Advances markets.businessinsider.com - March 28 at 8:07 AM

New MarketBeat Followers Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Wall Street tumbles after dispiriting data on the economy, as Meta sinks
April 25, 2024 2:14 AM
View Stock market today: Wall Street tumbles after dispiriting data on the economy, as Meta sinks
Foot Locker Builds Up Another Head of Steam; Gains Imminent
March 28, 2024 10:58 AM
View Foot Locker Builds Up Another Head of Steam; Gains Imminent
5 Stocks in the Current Bull Market with Upside to Come
April 5, 2024 10:14 AM
View 5 Stocks in the Current Bull Market with Upside to Come
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
April 22, 2024 6:05 AM
View Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?

All Headlines

Company Descriptions

Cabot Oil & Gas

NYSE:COG

Cabot Oil & Gas Corp. engages in the development, exploitation, production and exploration of oil and natural gas properties. It operates through the Marcellus shale in Pennsylvania. The company was founded in 1989 and is headquartered in Houston, TX.

Oncolytics Biotech

TSE:ONC

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep, as well as with Roche Holding AG. The company was incorporated in 1998 and is headquartered in Calgary, Canada.

Relx

NYSE:RENX

RELX NV, through its interest in RELX Group plc, provides information and analytics for professional and business customers across industries worldwide. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment offers information and analytics to institutions and professionals. The Risk & Business Analytics segment provides solutions and decision tools that combine public and industry specific content with technology and analytics to evaluate and predict risk, as well as enhance operational efficiency. The Legal segment offers legal, regulatory, and business information and analytics. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier NV and changed its name to RELX NV in June 2015. RELX NV was incorporated in 1880 and is headquartered in Amsterdam, the Netherlands.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial